MLYSMineralys Therapeutics, Inc.

$25.88

Who owns MLYS

212 institutions reported holding MLYS for 2026Q1, together 109% of the company, fewer than the 221 a quarter earlier.

212

Institutions reporting a position · as of 2026Q1 · down from 221 the quarter before

Shares held by institutions
90.3M

Shares held by institutions · 109% of the company · long US equity positions only, as reported on Form 13F

Reported value
$2.46B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
37%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
13
New positions
26
Positions exited
41
Added to
95
Reduced
48
Top 10 holdersof the company
55%
Institutional ownership by quarter, 2023Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q121290.3M$2.46B
2025Q422188.4M$3.21B
2025Q319179.3M$3.01B
2025Q216465.7M$889M
2025Q114760.8M$966M
2024Q410746.5M$572M
2024Q310444.3M$539M
2024Q29244.1M$516M
2024Q19241.9M$541M
2023Q48734.7M$299M
2023Q37726.5M$252M
2023Q26825.2M$429M
2023Q16724.6M$385M
Largest reported holders, 2026Q1
HolderShares% of companyValue
Catalys Pacific, LLC7.9M9.5%$214M
RA CAPITAL MANAGEMENT, L.P.7.7M9.3%$208M
SAMSARA BIOCAPITAL, LLC5.9M7.1%$159M
FMR LLC4.9M5.9%$132M
BlackRock Inc.4.5M5.4%$121M
VANGUARD GROUP INC3.6M4.4%$98M
WELLINGTON MANAGEMENT GROUP LLP3.4M4.1%$91M
STATE STREET CORP2.9M3.5%$80M
Caligan Partners LP2.8M3.3%$75M
Laurion Capital Management LP2.2M2.7%$60M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…